O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir

Authors :: Christine Rouzioux
Stéphane De Wit
Nadège Delacourt
Gilles Darcis
Olivier Rohr
Benoît Van Driessche
Carine Van Lint
Caroline Vanhulle
Anna Kula
Sophie Bouchat
Source :: Journal of Virus Eradication, Vol 2, Iss, Pp 2-(2016)
Publication Year :: 2016
Publisher :: Elsevier, 2016.

Subjects :: Epidemiology
business.industry
Immunology
Public Health, Environmental and Occupational Health
Human immunodeficiency virus (HIV)
medicine.disease_cause
Microbiology
QR1-502
Infectious Diseases
Virology
Medicine
Reversing
Latency (engineering)
Public aspects of medicine
RA1-1270
business
Ex vivo

Tools